A drug molecule is not a medicine. Turning it into something a patient can take requires formulation, the craft of combining the active ingredient with excipients to create a stable, effective, and manufacturable product. Formulation scientists decide whether the drug becomes a tablet, a capsule, a liquid, or something else. They choose the fillers, binders, coatings, and packaging. They test how the product dissolves, how long it lasts on the shelf, and whether it survives the journey through the body.

The work is part science and part engineering. A drug that is poorly soluble may need to be milled into nanoparticles or formulated as a salt. A drug that degrades in stomach acid may need an enteric coating that dissolves only in the intestine. A drug that tastes bitter may need a capsule shell or a flavoring agent. A drug that must release slowly may be embedded in a polymer matrix. Each decision affects how the drug behaves in the body and how easy it is to manufacture at scale.

Formulation considerations:

• Solubility. Can the drug dissolve in the gut?
• Stability. Will it degrade before the expiration date?
• Release profile. Immediate, delayed, or extended release?
• Patient acceptability. Can they swallow it? Does it taste acceptable?
• Manufacturability. Can it be made consistently at scale?

A change in formulation can change a drug's bioavailability, which is why regulators require bioequivalence studies for generic products.